People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Novita Pharmaceuticals, Inc. | — | Biotechnology | Series A | $10.9M | $86.4M | 2010 |
Xin-Yun Y. Huang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Xin-Yun Y. Huang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christy Y. Shue | 1 | 1 |
| Jue Jullian Zhang | 1 | 1 |
| David Jillian Moy | 1 | 1 |
| Chenjian Jillian Li | 1 | 1 |
| Jonathan Jia Zhu | 1 | 1 |
| Jue Jillian Zhang | 1 | 1 |
| Chenjian Jullian Li | 1 | 1 |
| David Jullian Moy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.